B-type natriuretic peptide (BNP) antibody and antigen (Recombinant protein)
Diagnostic B-type natriuretic peptide (BNP) antibodies (anti-B-type natriuretic peptide, anti-BNP) and antigens (recombinant B-type natriuretic peptide (BNP) protein) for Cardiovascular disease BNP detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Cardiovascular disease diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-BNP-Ag01 | Recombinant human BNP Protein | $3090.00 |
GMP-h-BNP-Ab01 | Anti-human BNP mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-BNP-Ab02 | Anti-human BNP mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-BNP-Ab03 | Anti-human BNP human monoclonal antibody (mAb) | $1953.00 |
GMP-h-BNP-Ab04 | Anti-human BNP human monoclonal antibody (mAb) | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Pruducts | GMP-h-BNP-Ag01 |
Product Name | Recombinant human BNP Protein |
Target/Biomarker | B-type natriuretic peptide (BNP) |
Alias of Target/Biomarker | BNP, Iso-ANP |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | B-type natriuretic peptide (BNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation |
Products description | Recombinant Human B-type natriuretic peptide (BNP) protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-BNP-Ab01,GMP-h-BNP-Ab02 |
Product Name | Anti-human BNP mouse monoclonal antibody (mAb) |
Target/Biomarker | B-type natriuretic peptide (BNP) |
Alias of Target/Biomarker | BNP, Iso-ANP |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human B-type natriuretic peptide (BNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other B-type natriuretic peptide (BNP) antibodies in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human BNP mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other B-type natriuretic peptide (BNP) antibodies. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-BNP-Ab03,GMP-h-BNP-Ab04 |
Product Name | Anti-human BNP human monoclonal antibody (mAb) |
Target/Biomarker | B-type natriuretic peptide (BNP) |
Alias of Target/Biomarker | BNP, Iso-ANP |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human B-type natriuretic peptide (BNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other B-type natriuretic peptide (BNP) antibodies in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human BNP mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Target/Biomarker information
BNP) in response to increased mechanical load and wall stretch. BNP protects the heart from adverse consequences of overload by increasing natriuresis and diuresis, relaxing vascular smooth muscle, inhibiting the renin-angiotensin-aldosterone system, and by counteracting cardiac hypertrophy and fibrosis. BNP is synthesized by human cardiac myocytes as a 108-amino acid prohormone (proBNP), which is cleaved to the 32-residue BNP and the 76-residue N-terminal fragment of proBNP (NT-proBNP). Both can be used as sensitive biomarkers of cardiac dysfunction and well-characterized commercial assays have recently become available. In acute coronary syndromes increased concentrations are strong predictors of recurring myocardial infarction, heart failure, and death. In acute dyspnea, high BNP and NT-proBNP point to a cardiac rather than a pulmonary origin of the symptoms. BNP and NT-proBNP help in the assessment of the severity of ventricular dysfunction and heart failure and as a prognostic predictor, regardless of the primary cause of the condition.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.